Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for patient needs across a variety of therapeutic areas including: pain management, mental health, gut health, diabetes, and allergies.

Medlab specialise in solutions that can provide improved bioavailability leading to better outcomes, fewer side effects and improved quality of life through agile innovative research and expertise in both large and small molecule delivery, throughout the entire supply chain process, from concept to the manufactured end product.

KEY PEOPLE

  • Dr Sean Hall, CEO, Executive Director

    Founding member, and CEO of Medlab Clinical LTD.
    Co-authored on multiple patents and publications, active within Medicines Australia, Research Australia, A4M, SOMA, and AusBiotech. Invitational speaker at various food, nutritional and pharmaceutical events and consult on therapeutic development and translational research.

    read more

  • Michael Hall, Non Executive Chairman

    Previously worked in chartered accountants offices, Michael joined Grace Brothers in their development phase and rose to be Head Office Controller. After approximately 8 years at Grace Brothers Michael left to have a short stint with Norman Ross (Harvey Norman) and then onto a private merchant bank. Michael became ill with cancer and his experience with that disease introduced him to the area of nutrition. Since that time Michael has been a key player in the successful building of various vitamin companies.

    read more

  • Cheryl Maley, Independent Director

    Cheryl, has pharmaceutical experience including over 20 years in roles across sales, marketing, business development, commercial excellence, patient access and general management. During her US (Chicago-based for three years) and Asia tenure (Philippines-based for three years), Mrs Maley focused in seeing products through to regulatory approval; and has gained knowledge of the oncology market.

    read more

  • Laurence McAllister, Independent Director

    McAllister is currently CEO of McPherson’s Limited. Under his leadership McPherson’s has delivered an impressive turnaround, growing annual sales revenue to $220M. He brings strong experience in consumer marketing and extensive commercial, M&A and business strategy experience. Mr. McAllister was previously Managing Director for Sanofi in Australia & New Zealand, where he successfully led and turned around the company’s consumer healthcare business. During his tenure at Sanofi he also served on the Board of Medicines Australia for two years.

    read more

  • Drew Townsend, Independent Director

    Chairman at Quantum Health Group Ltd and also on the board of Medlab Clinical Ltd. and Member of Australian Institute of Co. Directors, Member of The Institute of Chartered Accountants in Australia, Member of The Institute of Internal Auditors (Australia), Member of Governance Institute of Australia Ltd. and Member of Chartered Accountants Australia & New Zealand.

    Mr. Townsend previously was Senior Partner at Hall Chadwick.

    read more

RELATED STOCKHEAD STORIES